Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis
暂无分享,去创建一个
JoAnn E. Manson | Meir J. Stampfer | Elizabeth W. Karlson | Carolyn C. Cannuscio | Daniel H. Solomon | Gary C. Curhan | J. Manson | E. Rimm | M. Stampfer | E. Karlson | G. Curhan | D. Solomon | L. Mandl | C. Cannuscio | Eric B. Rimm | Lisa A. Mandl
[1] R. Monson,et al. Mortality among arthritics. , 1976, Journal of chronic diseases.
[2] P. Allebeck. Increased mortality in rheumatoid arthritis. , 1982, Scandinavian journal of rheumatology.
[3] M. Petri. Biochemical characterization of ADP-ribose polymer metabolism in SLE. , 1996 .
[4] W. Willett,et al. Test of the National Death Index. , 1984, American journal of epidemiology.
[5] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.
[6] G L Freeman,et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.
[7] P. Ridker,et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. , 1998, Circulation.
[8] Thomas G. Whiston,et al. A National Survey , 1992 .
[9] D. Symmons. Mortality in rheumatoid arthritis. , 1988, British journal of rheumatology.
[10] P. Ridker,et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. , 1997, The New England journal of medicine.
[11] F. D. Weinfeld,et al. The National Survey of Stroke. Clinical findings. , 1981, Stroke.
[12] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[13] C. Helmick,et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. , 1998, Arthritis and rheumatism.
[14] A. Rebuzzi,et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.
[15] CLINICAL FINDINGS , 1978, WHO regional publications. European series.
[16] R B D'Agostino,et al. Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. , 1990, Statistics in medicine.
[17] H. Blackburn,et al. Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.
[18] J. Sánchez-Guerrero,et al. A connective tissue disease screening questionnaire for population studies. , 1995, Annals of epidemiology.
[19] F. Speizer,et al. The Nurses' Health Study , 1978, The American journal of nursing.
[20] G. Alarcón,et al. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. , 1998, The Journal of rheumatology.
[21] S. Cobb,et al. Length of life and cause of death in rheumatoid arthritis. , 1953, The New England journal of medicine.
[22] D. Nashel. Is atherosclerosis a complication of long-term corticosteroid treatment? , 1986, The American journal of medicine.
[23] Lise,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.
[24] R. Frye,et al. T-cell immunity in acute coronary syndromes. , 2001, Mayo Clinic proceedings.
[25] J. Manson,et al. The Nurses' Health Study: 20-year contribution to the understanding of health among women. , 1997, Journal of women's health.
[26] R. Frye,et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. , 2000, Circulation.
[27] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[28] M. Petri,et al. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. , 1996, Lupus.
[29] D. Wallace,et al. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids. , 1990, The American journal of medicine.
[30] D. Redelmeier,et al. The treatment of unrelated disorders in patients with chronic medical diseases. , 1998, The New England journal of medicine.
[31] S. R. Dahlqvist,et al. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. , 1997, The Journal of rheumatology.
[32] P. Allebeck. Increased Mortality in Rheumatoid Arthritis: The Use of a Medical Information System for Assessment of Death Risks , 1982 .
[33] James M Robins,et al. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study , 2002, The Lancet.
[34] H. Kautiainen,et al. Cardiovascular mortality in women with rheumatoid arthritis. , 1995, The Journal of rheumatology.
[35] P. Shekelle,et al. Quality of care for patients with rheumatoid arthritis. , 2000, JAMA.
[36] T. Pincus,et al. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. , 1984, Arthritis and rheumatism.